In:
Interventional Cardiology Review, Radcliffe Media Media Ltd, Vol. 12, No. 01 ( 2017), p. 36-
Abstract:
Transcatheter aortic valve implantation (TAVI) is a less invasive aortic valve replacement technique and is indicated for patients with symptomatic severe aortic stenosis and a high operative risk. Cerebral embolisation seems inherent to TAVI, as illustrated by the consistent appearance of new brain lesions on post-procedural MRI studies. Embolic protection devices may capture or deflect embolised material en route to the brain and thus reduce TAVI-related brain injury. Histopathology studies of captured debris revealed a diverse aetiology including recent or organised thrombotic material, tissue originating from the aortic valve, atherosclerotic plaques or myocardium and foreign body components. In this overview we provide a perspective on current evidence and implications for embolic protection devices in the dynamic TAVI field.
Type of Medium:
Online Resource
ISSN:
1756-1477
DOI:
10.15420/icr.2016:30:2
Language:
English
Publisher:
Radcliffe Media Media Ltd
Publication Date:
2017
detail.hit.zdb_id:
2813989-6
Bookmarklink